Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-04-19

FDA Approved: THALITONE — Supplemental Application (Casper Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for THALITONE (chlorthalidone) submitted by Casper Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • THALITONE (chlorthalidone)

Snippet

SUPPL AP for THALITONE (CHLORTHALIDONE)